Chemoinformaics analysis of 13-Tigloyloxylupanine
Molecular Weight | 346.471 | nRot | 2 |
Heavy Atom Molecular Weight | 316.231 | nRig | 23 |
Exact Molecular Weight | 346.226 | nRing | 4 |
Solubility: LogS | -2.476 | nHRing | 4 |
Solubility: LogP | 2.381 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 4 |
No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 58.0098 |
nHD | 0 | BPOL | 36.9882 |
QED | 0.57 |
Synth | 5.044 |
Natural Product Likeliness | 1.435 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.157 |
Pgp-sub | 0.004 |
HIA | 0.035 |
CACO-2 | -4.733 |
MDCK | 0.0000295 |
BBB | 0.495 |
PPB | 0.600309 |
VDSS | 1.434 |
FU | 0.446321 |
CYP1A2-inh | 0.029 |
CYP1A2-sub | 0.115 |
CYP2c19-inh | 0.079 |
CYP2c19-sub | 0.656 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.268 |
CYP2d6-inh | 0.947 |
CYP2d6-sub | 0.674 |
CYP3a4-inh | 0.069 |
CYP3a4-sub | 0.875 |
CL | 8.926 |
T12 | 0.662 |
hERG | 0.016 |
Ames | 0.007 |
ROA | 0.01 |
SkinSen | 0.932 |
Carcinogencity | 0.234 |
EI | 0.05 |
Respiratory | 0.419 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.73335 |